Microsecond molecular dynamics simulation of A?42 and identification of a novel dual inhibitor of A?42 aggregation and BACE1 activity.
Ontology highlight
ABSTRACT: AIM: To study the conformational changes of A?42 and discover novel inhibitors of both A?42 aggregation and ?-secretase (BACE1). METHODS: A molecular dynamics (MD) simulation at a microsecond level was performed to explore stable conformations of A?42 monomer in aqueous solution. Subsequently, structure-based virtual screening was used to search for inhibitors of both A?42 aggregation and BACE1. Protein purification and in vitro activity assays were performed to validate the inhibition of the compounds identified via virtual screening. RESULTS: The initial ?-helical conformation of A?42, which was unstable in aqueous solution, turned into a ?-sheet mixed with a coil structure through a transient and fully random coil. The conformation of A?42 mainly comprising ?-sheets and coils structure was used for further virtual screening. Five compounds were identified as inhibitors for A?42 aggregation, and one of them, AE-848, was discovered to be a dual inhibitor of both A?42 aggregation and BACE1, with IC50 values of 36.95 ?mol/L and 22.70 ?mol/L, respectively. CONCLUSION: A helical to ?-sheet conformational change in A?42 occurred in a 1.8 microsecond MD simulation. The resulting ?-sheet structure of the peptide is an appropriate conformation for the virtual screening of inhibitors against A?42 aggregation. Five compounds were identified as inhibitors of A?42 aggregation by in vitro activity assays. It was particularly interesting to discover a dual inhibitor that targets both A?42 aggregation and BACE1, the two crucial players in the pathogenesis of Alzheimer's disease.
SUBMITTER: Wang YY
PROVIDER: S-EPMC4003156 | biostudies-literature | 2013 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA